Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Chlamydia and Gonorrhea: Screening

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: September 2021

Workgroups: Sexually Transmitted Infections Workgroup, Access to Health Services Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends screening for chlamydia and gonorrhea in sexually active women age 24 years or younger. In sexually active women age 25 years or older, USPSTF recommends screening only if there’s an increased risk of infection. USPSTF found insufficient evidence to assess whether the benefits of screening for chlamydia and gonorrhea in sexually active men outweigh the harms.

Read more about this resource

Objectives related to this resource (2)

Increase the proportion of sexually active female adolescents and young women who get screened for chlamydia — STI‑01
Little or no detectable change
Increase the proportion of adults who get recommended evidence-based preventive health care — AHS‑08
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2021). Final recommendation statement: Chlamydia and gonorrhea: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening